This trial is evaluating whether BXCL501 will improve 1 primary outcome and 1 secondary outcome in patients with Schizophrenia. Measurement will happen over the course of 120 minutes.
This trial requires 120 total participants across 3 different treatment groups
This trial involves 3 different treatments. BXCL501 is the primary treatment being studied. Participants will be divided into 2 treatment groups. Some patients will receive a placebo treatment. The treatments being tested are in Phase 1 and are in the first stage of evaluation with people.
"There are several common treatments for disease. The most common treatment for pain such as diabetic neuropathy, is opioids and antineuronal agents. Chronic disease such as coronary heart disease, is treated with aspirin and medication used to lower blood pressure and blood cholesterol levels. A treatment for chronic heart failure is to help the patient remain active and healthy by providing support for the patient to do regular physical activities to lower blood pressure and cholesterol levels." - Anonymous Online Contributor
"There are many different diseases that can lead to a fatal illness. If you do not want to die, and you get sicker and sicker, you need a doctor. There is no one way to get better. It seems crazy, but in a lot of ways it's the world we construct. I've got plenty of luck in this life, and I'd be happy to take it." - Anonymous Online Contributor
"It is impossible to restore a nondiseasurable health condition to an absolute health state. It is possible to do as close as possible to that state without restoring the patient to complete health. That is to say, it is possible with reasonable medical care to make a patient healthier, and not to make it healthy." - Anonymous Online Contributor
"The term disease has been given many different meanings since ancient times. It is more useful to view disease as a process whereby the organism behaves differently to its ancestors and different from its peers and descendants or where the organism responds differently to the environment. Disease can be defined as any condition or event in an organism that significantly compromises its normal biological functions.\n\nIt has been suggested that, to have a sense, the expression of disease must be socially constructed and not only determined by a biological process. The social construction of disease, therefore, is a fundamental aspect of biological pathogenesis. Within the discipline of medical anthropology, the concept of disease has been interpreted in many ways." - Anonymous Online Contributor
"The American Cancer Society estimates about 200,000 deaths from cancer a year in the United States. Cancer deaths are more likely to occur after the age of 65. In the United States, cancer is now the most common disease-related cause of death. The rate of cancer death is highest in the 20- to 44-year age group and then declines to a steady level with age. Survival times are lengthened in blacks and for females aged 46 to 54 years, with the exception of colon cancer, in women aged 45 to 49 years old." - Anonymous Online Contributor
"The authors concluded with their recommendation to pay attention to the following signs or symptoms as they might suggest or help to differentiate lung problems from respiratory diseases: breathlessness, cough, chest pain, abnormal chest X-ray appearance, loss of appetite, vomiting, a low or fast heart rate, abnormal breathing sounds, sweating, or diarrhea.\n\nInfection is not necessarily a sign of disease. In fact, the infections that are linked to an increased risk of developing disease can be of benefit to the body.\nInfection is also associated with an increased risk of developing cancer and other diseases. It is thought that both the body's immune system and infection by microbes can affect immune response to the body." - Anonymous Online Contributor
"Bxcl501 is an experimental drug that targets blood and brain barrier permeability thereby lowering intracerebral edema and hemorrhage. It is being studied in clinical trials by Novartis for the treatment of intracerebral hemorrhage." - Anonymous Online Contributor
"The majority of respondents described their overall treatment experience with Bxcl501 as supportive and effective. They also reported that Bxcl501 was most effective for treatment of BXD2. In all, 80% of respondents described their treatment with Bxcl501 with improvement or stabilization of symptoms, and in 93% of cases there was an appreciable effect on life expectancy. These responses are in line with results from published clinical trials. Overall, Bxcl501 was well tolerated, and treatment was mostly discontinued or interrupted based on tolerability or side effects." - Anonymous Online Contributor
"The bxcl501 molecules present a highly successful antiviral strategy against human T-lymphotropic-virus type 1 HIV-related neurosarcoidosis. Bxcl501 is working in vivo in an animal model of neurosarcoidosis, and phase I and II human clinical trials have indicated that this may be a promising approach for treating the disease. In conclusion, these studies are ongoing, and further developments are expected." - Anonymous Online Contributor
"The risk of death associated with asthma is not as high as doctors expected, even in young children who experience serious health problems. Doctors and patients should agree on the disease severity index to help direct the health-care team toward management of health problems, particularly in low-resource settings without access to care for patients in need of medical services." - Anonymous Online Contributor
"Bxcl501 was well tolerated and showed activity in patients with advanced ovarian cancer previously treated or in combination with paclitaxel and doxorubicin. A prospective clinical trial in early-stage ovarian cancer with this regimen is now ongoing." - Anonymous Online Contributor
"Bxcl501 is not associated with any serious side effect but does have common side effects, such as headache, dizziness and blurred vision. The side effects can be controlled and managed by the patients and healthcare professionals. [power(https://www.withpower." - Anonymous Online Contributor